Repurposing drugs: a missed opportunity

4 min read

Key principles and suggestions to foster collaboration and unleash the potential of repurposing drugs, for more equal and accessible healthcare. We can’t learn, be active citizens, get a job, or be a part of a group unless we have good health. This means that every country needs to make research and availability of drugs a top priority. That has been exacerbated by the current pandemic. Life Science research has always been a key part of how humans have grown and changed. Research for new drugs is difficult. Accessible treatments are even harder. Under current life sciences models, companies are less…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.